✦ LIBER ✦

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

✍ Scribed by Kang, Y.-K.; Kang, W.-K.; Shin, D.-B.; Chen, J.; Xiong, J.; Wang, J.; Lichinitser, M.; Guan, Z.; Khasanov, R.; Zheng, L.; Philco-Salas, M.; Suarez, T.; Santamaria, J.; Forster, G.; McCloud, P. I.

Book ID: 125529274
Publisher: Oxford University Press
Year: 2009
Tongue: English
Weight: 331 KB
Volume: 20
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdn717

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3501 ORAL Capecitabine/cisplatin vs. con

3501 ORAL Capecitabine/cisplatin vs. continuous infusion of 5-FU/cisplatin as first-line therapy in patients (pts) with advanced gastric cancer (AGC): a randomised phase III trial

✍ Y. Kang; W. Kang; D. Shin; J. Chen; J. Xiong; J. Wang; M. Lichinitser; M. Philco 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Phase II trial of capecitabine plus cisp

Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer

✍ Daniel T. T. Chua; Harry Ho-Yin Yiu; Kasan Seetalarom; Alice Wan-Ying Ng; Johan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

A randomized Phase III trial of etoposid

A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma

✍ Fikri İçli; İsmail Çelik; Faruk Aykan; Aytuǧ Üner; Ahmet Demirkazik; Ahmet Özet; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with adv

P51 Randomised, single-centre, phase 2 t

P51 Randomised, single-centre, phase 2 trial of nimotuzumab plus cisplatin and S-1 as first-line therapy in patients with advanced gastric cancer

✍ Y. Chi; J. Wang; Z. Zheng; A. Zhou; L. Yang; T. Qu; W. Jiang; S. Shi; Y. Sun; Y. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

740 POSTER Fluorouracil, leucovorin and

740 POSTER Fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP) as a first line therapy in patients with advanced gastric cancer —interim analysis of a multicenter, randomized phase II trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 302 KB

A prospective randomized phase III trial

A prospective randomized phase III trial of 5-fluorouracil and cisplatin (FP) versus epirubicin, cisplatin, and 5-fu (ECF) in the treatment of patients with previously untreated advanced gastric cancer (AGC)

✍ Kim, T.W.; Choi, S.J.; Ahn, J.H.; Bang, H.S.; Chang, H.M.; Kang, Y.K.; Lee, J.S. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB